iShares U.S. Pharmaceuticals ETF (IHE)

189.07
BATS BZX Real-Time Price
As of Nov 29
 -0.15 / -0.08%
Today’s Change
170.29
Today|||52-Week Range
199.51
+5.37%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Performance

1 month+0.48% 3 years+8.17%
3 months-1.76% 5 years+7.50%
1 year+11.57% Since inception+10.45%
Data through 11/30/2021

Quote Details

Previous close$189.22
Open day’s range189.07 – 189.28
Net asset value (NAV)188.95 (11/29/2021)
Daily volume4,654
Average volume (3 months)5,734
Data as of 3:54pm ET, 11/29/2021

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+7.50%+13.75%
Expense Gross exp ratio0.42%1.00%
Risk 5 year sharpe ratio0.510.91
Net assets$376.1M$2.4B
Average market cap$60.0B$37.7B
Average P/E19.525.0
Dividend / Share--0.29%

Competitors

RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson21.90%
PFE Pfizer18.91%
MRK Merck5.40%
ZTS Zoetis Inc4.78%
RPRX Royalty Pharma PLC4.72%
LLY Eli Lilly and Co4.62%
ELAN Elanco Animal Health Inc4.49%
CTLT Catalent Inc4.48%
VTRS Viatris Inc4.24%
BMY Bristol-Myers Squibb4.16%